Psychedelic Therapies in the United States — Balancing State and Federal Oversight

The provided text is extremely brief, containing only the article title: 'Psychedelic Therapies in the United States — Balancing State and Federal Oversight'. From this short excerpt, it is not possible to create a factual summary of 6-8 sentences that would include verified information, statistics, or details on the topic. The article, published in the New England Journal of Medicine, Volume 394, Issue 23, on pages 2281-2283 on June 18, 2026, presumably addresses the complex issue of regulating psychedelic therapies in the U.S. Specifically, it focuses on the challenges associated with coordinating and differentiating between state and federal oversight of these therapies. Without the full article content, it is not possible to provide more detailed facts or statistics.